Prognostic Use of Soluble Fms-Like Tyrosine Kinase-1 and Placental Growth Factor in Patients With Coronary Artery Disease

References

• Chen YX , NakashimaY, TanakaK, ShiraishiS, NakagawaK, SueishiK. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler. Thromb. Vasc. Biol.19(1), 131–139 (1999).
   Web of Science ®Google Scholar
• Dutta P , CourtiesG, WeiYet al. Myocardial infarction accelerates atherosclerosis. Nature487(7407), 325–329 (2012).
   PubMed Web of Science ®Google Scholar
• Inoue M , ItohH, UedaMet al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation98(20), 2108–2116 (1998).
   PubMed Web of Science ®Google Scholar
• Libby P . Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol.32(9), 2045–2051 (2012).
   PubMed Web of Science ®Google Scholar
• Lei Y , HaiderH, ShujiaJ, SimES. Therapeutic angiogenesis. Devising new strategies based on past experiences. Basic Res. Cardiol.99(2), 121–132 (2004).
   Web of Science ®Google Scholar
• Yu Y , GaoY, QinJet al. CCN1 promotes the differentiation of endothelial progenitor cells and reendothelialization in the early phase after vascular injury. Basic Res. Cardiol.105(6), 713–724 (2010).
   PubMed Web of Science ®Google Scholar
• Lassaletta AD , ChuLM, SellkeFW. Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res. Cardiol.106(6), 897–909 (2011).
   Web of Science ®Google Scholar
• Kristen AV , RinnJ, HegenbartUet al. Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor. Clin. Res. Cardiol.104(3), 250–257 (2015).
   Web of Science ®Google Scholar
• Kurz K , VoelkerR, ZdunekDet al. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin. Res. Cardiol.96(3), 152–159 (2007).
   PubMed Web of Science ®Google Scholar
• Autiero M , LuttunA, TjwaM, CarmelietP. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J. Thromb. Haemost.1(7), 1356–1370 (2003).
   PubMed Web of Science ®Google Scholar
• De Falco S , GiganteB, PersicoMG. Structure and function of placental growth factor. Trends Cardiovasc. Med.12(6), 241–246 (2002).
   Web of Science ®Google Scholar
• Ribatti D . The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis11(3), 215–221 (2008).
   PubMed Web of Science ®Google Scholar
• Luttun A , TjwaM, CarmelietP. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann. NY Acad. Sci.979, 80–93 (2002).
   PubMed Web of Science ®Google Scholar
• Luttun A , TjwaM, MoonsLet al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med.8(8), 831–840 (2002).
   PubMed Web of Science ®Google Scholar
• Zimmet JM , HareJM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res. Cardiol.100(6), 471–481 (2005).
   Web of Science ®Google Scholar
• Zengin E , ChalajourF, GehlingUMet al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development133(8), 1543–1551 (2006).
   PubMed Web of Science ®Google Scholar
• Bui AH , BonacaMP, SabatineMSet al. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial. J. Thromb. Thrombolysis34(2), 222–228 (2012).
   PubMed Web of Science ®Google Scholar
• Heeschen C , DimmelerS, FichtlschererSet al. Prognostic value of placental growth factor in patients with acute chest pain. JAMA291(4), 435–441 (2004).
   PubMed Web of Science ®Google Scholar
• Hochholzer W , ReichlinT, StelzigCet al. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. Eur. Heart J.32(3), 326–335 (2011).
   PubMed Web of Science ®Google Scholar
• Lenderink T , HeeschenC, FichtlschererSet al. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J. Am. Coll. Cardiol.47(2), 307–311 (2006).
   PubMed Web of Science ®Google Scholar
• Matsumoto T , UemuraS, TakedaYet al. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease. Intern. Med.52(10), 1019–1027 (2013).
   PubMed Web of Science ®Google Scholar
• Iwama H , UemuraS, NayaNet al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J. Am. Coll. Cardiol.47(8), 1559–1567 (2006).
   PubMed Web of Science ®Google Scholar
• Ky B , FrenchB, RuparelKet al. The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. J. Am. Coll. Cardiol.58(4), 386–394 (2011).
   PubMed Web of Science ®Google Scholar
• Zengin E , SinningC, ZellerTet al. Activity of superoxide dismutase copper/zinc type and prognosis in a cohort of patients with coronary artery disease. Biomark. Med.9(6), 597–604 (2015).
   Web of Science ®Google Scholar
• Zengin E , SinningC, ZellerTet al. The utility of pregnancy-associated plasma protein A for determination of prognosis in a cohort of patients with coronary artery disease. Biomark. Med.9(8), 731–741 (2015).
   PubMed Web of Science ®Google Scholar
• Zengin E , BickelC, SchnabelRBet al. Risk factors of coronary artery disease in secondary prevention–results from the AtheroGene study. PLoS ONE10(7), e0131434 (2015).
   Web of Science ®Google Scholar
• Belgore FM , BlannAD, LipGY. Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays. Clin. Sci. (Lond.)100(5), 567–575 (2001).
   PubMed Web of Science ®Google Scholar
• Levine RJ , MaynardSE, QianCet al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med.350(7), 672–683 (2004).
   PubMed Web of Science ®Google Scholar
• Hanley JA , McneilBJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology143(1), 29–36 (1982).
   PubMed Web of Science ®Google Scholar
• Delong ER , DelongDM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics44(3), 837–845 (1988).
   PubMed Web of Science ®Google Scholar
• Jungbauer CG , RiedlingerJ, BlockDet al. Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure. Biomark. Med.8(6), 777–789 (2014).
   PubMed Web of Science ®Google Scholar
• Chung NA , LydakisC, BelgoreF, Li-Saw-HeeFL, BlannAD, LipGY. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart89(12), 1411–1415 (2003).
   PubMed Web of Science ®Google Scholar
• Chung NA , LydakisC, BelgoreF, BlannAD, LipGY. Angiogenesis in myocardial infarction. An acute or chronic process?Eur. Heart J.23(20), 1604–1608 (2002).
   Web of Science ®Google Scholar
• Onoue K , UemuraS, TakedaYet al. Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction. Am. J. Cardiol.104(11), 1478–1483 (2009).
   PubMed Web of Science ®Google Scholar
• Onoue K , UemuraS, TakedaYet al. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis. Circulation120(24), 2470–2477 (2009).
   PubMed Web of Science ®Google Scholar
• Hojo Y , IkedaU, ZhuYet al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J. Am. Coll. Cardiol.35(4), 968–973 (2000).
   Web of Science ®Google Scholar
• Lee SH , WolfPL, EscuderoR, DeutschR, JamiesonSW, ThistlethwaitePA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med.342(9), 626–633 (2000).
   Web of Science ®Google Scholar
• Vasan RS . Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation113(19), 2335–2362 (2006).
   PubMed Web of Science ®Google Scholar